← Open Payments lookup

SUSAN GRANATO: Open Payments

NPI 1225688427 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,916 in 80 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $1,370 · 2025 $3,916

Food & beverage: $2,177Long term medical supply or device loan: $1,097Honoraria: $600Education: $43
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation16$1,231
Pharmacosmos Therapeutics Inc.3$679
BeOne Medicines USA, Inc.5$243
Incyte Corporation6$216
Fennec Pharmaceuticals, Inc.1$172
PharmaEssentia USA Corporation4$120
GENZYME CORPORATION1$114
Merck Sharp & Dohme LLC5$112
Janssen Biotech, Inc.5$101
Janssen Scientific Affairs, LLC1$83

Products named: KISQALI, COSELA, BRUKINSA, Fyarro, Jakafi, BESREMI, WAYRILZ, KEYTRUDA.

Industry payments across MD — which companies pay providers there.